Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etomidate With Meperidine vs Midazolam With Meperidine for Sedation During Endodscopic Retrograde Cholangiopancreatogram (ERCP)

NCT02027311 is registered in ClinicalTrials.gov with Cheju Halla General Hospital as lead sponsor.

NCT NCT02027311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etomidate With Meperidine vs Midazolam With Meperidine for Sedation During Endodscopic Retrograde Cholangiopancreatogram (ERCP)
Lead sponsor
Cheju Halla General Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2013
Completion date
August 31, 2013
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, choledocholithiasis, pancreatic cancer, pancreatitis